3
An extraordinary treatment for Parkinson’s. An exclusive chance to be a part of it.

An extraordinary treatment for Parkinson’s. An …Dr. Satish Khadilkar President at Indian Academy of Neurology. HOD, Bombay Hospital, Mumbai. Prof. Kalyan Bhattacharya President,

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: An extraordinary treatment for Parkinson’s. An …Dr. Satish Khadilkar President at Indian Academy of Neurology. HOD, Bombay Hospital, Mumbai. Prof. Kalyan Bhattacharya President,

An extraordinary treatment

for Parkinson’s.

An exclusive chance to be

a part of it.

Page 2: An extraordinary treatment for Parkinson’s. An …Dr. Satish Khadilkar President at Indian Academy of Neurology. HOD, Bombay Hospital, Mumbai. Prof. Kalyan Bhattacharya President,

National

Dr. Satish Khadilkar President at Indian Academy of Neurology.

HOD, Bombay Hospital, Mumbai.

Prof. Kalyan Bhattacharya President, Movement Disorders Society of India.

Prof. Mohit Bhatt Director of Neurology, Kokilaben Ambani Hospital, Mumbai.

Prof. Madhuri Behari Director of Movement Disorders, Fortis Hospitals, Delhi.

Prof. Neeta Shah Consulting Neurologist, Nanavati Superspecialty Hospital, Mumbai.

Prof. Ali Irani HOD, Physiotherapy & Rehabilitation

Nanavati Superspecialty Hospital, Mumbai.

Dr. Anil Venkitachalam Movement Disorders Specialist,

Nanavati Superspecialty Hospital, Mumbai.

Dr. Pradyuman Oak Neurologist, Nanavati Superspecialty Hospital, Mumbai.

Dr. Abdul S. Ansari Director at Critical Care, Nanavati Superspecialty Hospital, Mumbai.

Dr. Charulata Sankhla Movement Disorders Specialist, Hinduja Hospital Mumbai.

Prof. Jimmy Lalkaka Movement Disorders Specialist, Bombay Hospital, Mumbai.

Dr. Pankaj Agarwal Movement Disorders Specialist, Consultant at Global Hospital Mumbai.

Dr. Pettarusp Wadia Movement Disorders Specialist, Jaslok Hospital, Mumbai.

FACULTY

International

Prof. K. Ray Chaudhuri D.Sc., FRCP MD Professor of Movement Disorders

Clinical Director National Parkinson Foundation Centre of Excellence,

King’s College Hospital, London

Research Director and Assistant Medical Director,

King’s College Hospital

Co-lead Division 4 Nervous system, CLRN, Sth London

Member NIHR National Nervous Systems Committee Chairman.

IPMDS Non-motor Parkinson's Study Group

Dr. Vinod Metta MD (UK), DM (UK), MRCP (UK), MRCPS (Glas), FRCP (UK)

Consultant Interventional Neurologist & Movement Disorders Specialist,

King’s College & Imperial Hospitals, London

Mr. Robert Wood Bsc (Hons)., MBA (UK)

Managing Director, Britannia Pharmaceuticals, UK.

Director, EMEA @ Britannia (STADA) Pharmaceuticals Ltd

Mr. Constantino Savvinidis MBA (UK), International Business Lead Britannia Pharmaceuticals, UK

Mr. Simon Coles MBA (UK), Global Lead & Financial Director Britannia Pharmaceuticals, UK

16:00 Arrival of dignitaries & High Tea

16:30 Welcome speech by Dr. Rajendra Patankar (COO)

Lamp lighting by all dignitaries:

Dr. Deepak Sawant (Hon. Health Minister), Mr. Paresh Rawal,

Dr. Vinod Metta, Dr. Neeta Shah, Dr. Rajendra Patankar

& Dr. Deepak Patkar.

16:35 Overview of Parkinsonism in India and Need of the Hour

- APO Morphine by Dr. Neeta Shah

16:40 Video - Improvement of Patients by Dr. Vinod Metta

16:45 Speech by Hon. Health Minister, Dr. Deepak Sawant,

and Mr. Paresh Rawal.

Inauguration and unveiling of APO KITS.

Speaker

Dr. Neeta Shah

Prof. Madhuri Behari

Dr. Anil Venkitachalam

Robert Wood

Prof. K. Ray Chaudhuri

Dr. Vinod Metta

Prof. Kalyan Bhattacharya

Dr. Deepak Patkar

Chairpersons

Dr. Charulata Sankhla

Prof. Mohit Bhatt

Dr. Jimmy Lalkaka

Dr. Satish Khadilkar

Dr. Pankaj Agarwal

Dr. Pettarusp Wadia

SCHEDULE OF EVENTS

Time & Topic

17:00 - 17:30

Advanced Parkinson’s Disease:

Indian perspective and need for

advanced therapies

Continuous Dopaminergic Therapy:

When, What and Whom?

Continuous Dopaminergic therapy

on motor & Non-motor PD

Apomorphine - The molecule and

its impact (industry and general)

17:30 - 18:30

APO past present and future why is

APO a “different” dopamine agonist

APO - PEN & PUMP Dynamics

how to initiate, maintain and sustain

and titrate

Future of Parkinson’s Disease

Management

18:30

Vote of thanks

18:45

Dinner

(5th December 2018)

Page 3: An extraordinary treatment for Parkinson’s. An …Dr. Satish Khadilkar President at Indian Academy of Neurology. HOD, Bombay Hospital, Mumbai. Prof. Kalyan Bhattacharya President,

National Speakers

Prof. Kalyan BhattacharyaPresident, Movement Disorders

Society of India

Dr. Anil VenkitachalamMovement Disorders Specialist,

Nanavati Super Speciality Hospital, Mumbai

Prof. Madhuri BehariDirector of Movement Disorders,

Fortis Hospitals, Delhi

Mr. Robert WoodB.SC. (Hons), MBA (UK)

Managing Director, Britannia Pharmaceuticals, UK

Director, EMEA @ Britannia (STADA)

Pharmaceuticals Limited

Dr. Vinod MettaMD (UK), DM (UK), MRCP (UK),

MRCPS (Glas), FRCP (UK),

Consultant Interventional Neurologist &

Movement Disorders Specialist

King’s College & Imperial Hospitals, London

International Speakers

Prof. K. Ray ChaudhuriD.Sc., FRCP MD, Professor of Movement Disorders

Clinical Director, National Parkinson Foundation

Centre of Excellence, King’s College, Hospital, London

Research Director and Asst. Medical Director,

King’s College Hospital

Co-lead Division 4 Nervous System, CLRN, Sth London

Member – NIHR National Nervous Systems Committee

Chairman – IPMDS Non-motor Parkinson’s Study Group

S.V. Road, Vile Parle (W) | Call 022 2626 7500 | www.nanavatihospital.org

In collaboration with

Prof. Neeta Shah (Mehta)Senior Consultant Neurologist,

Nanavati Super Speciality Hospital, Mumbai